Stockscreener 앱 받기
11.69
0.68%
-0.09
Bioventus Inc 주식(BVS)의 최신 뉴스
The Technical Signals Behind (BVS) That Institutions Follow - Stock Traders Daily
Bioventus, Inc. Class A Revenue Breakdown – DUS:4B8 - TradingView
Average basic shares outstanding of Bioventus, Inc. Class A – DUS:4B8 - TradingView
BVS Maintained by Barrington Research -- Price Target at $14.00 - GuruFocus
Q1 2026 Bioventus Inc Earnings Call Transcript - GuruFocus
Q3 2025 Bioventus Inc Earnings Call Transcript - GuruFocus
Bioventus Inc (FRA:4B8)Valuation Measures & Financial Statistics - GuruFocus
Bioventus Inc (FRA:4B8) Stock Price & 30 Year Financial Data - GuruFocus
Bioventus Inc Stock Operating Data - GuruFocus
FRA:4B8 Dividend: Does Bioventus Inc Pay a Dividend? - GuruFocus
Who's Buying or Selling Bioventus Inc (FRA:4B8) Stock Today? - GuruFocus
Bioventus Inc (FRA:4B8) Stock News, Headlines & Updates - GuruFocus
Bioventus Inc (FRA:4B8) Stock Earnings Transcripts - GuruFocus
Form DEF 14A Bioventus Inc For: 26 June By Investing.com - Investing.com Nigeria
Bioventus, Inc. Class A Actuals & Estimates (NASDAQ:BVS) - TradingView
Price to earnings forward of Bioventus, Inc. Class A – FWB:4B8 - TradingView
Price to earnings forward of Bioventus, Inc. Class A – TRADEGATE:4B8 - TradingView
Bioventus, Inc. Class A Actuals & Estimates (FWB:4B8) - TradingView
BVS Forecast — Price Target — Prediction for 2027 - TradingView
4B8 Forecast — Price Target — Prediction for 2027 - TradingView
Should Value Investors Buy Bioventus (BVS) Stock? - Yahoo Finance
Enterprise value to EBITDA forward of Bioventus, Inc. Class A – FWB:4B8 - TradingView
Enterprise value to revenue forward of Bioventus Inc. – NASDAQ:BVS - TradingView
Price to book forward of Bioventus Inc. – NASDAQ:BVS - TradingView
Long term debt to total equity ratio of Bioventus, Inc. Class A – FWB:4B8 - TradingView
Book value per share of Bioventus, Inc. Class A – FWB:4B8 - TradingView
Total debt per share of Bioventus, Inc. Class A – FWB:4B8 - TradingView
Bioventus, Inc. Class A Trade Ideas — FWB:4B8 - TradingView
BVS Technical Analysis & Stock Price Forecast - Intellectia AI
Precision Trading with Bioventus Inc. (BVS) Risk Zones - Stock Traders Daily
Bioventus Inc (BVS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bioventus Inc (BVS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bioventus Inc (BVS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bioventus Inc (BVS) Institutional Confidence - TradingKey
Bioventus Inc (BVS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bioventus Inc (BVS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bioventus Inc (BVS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioventus Inc (BVS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioventus Inc (BVS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
EBIT per share of Bioventus, Inc. Class A – TRADEGATE:4B8 - TradingView
After tax other income/expense of Bioventus, Inc. Class A – TRADEGATE:4B8 - TradingView
Asset turnover of Bioventus, Inc. Class A – TRADEGATE:4B8 - TradingView
Bioventus, Inc. Class A Statistics – TRADEGATE:4B8 - TradingView
Bioventus, Inc. Class A Trade Ideas — TRADEGATE:4B8 - TradingView
BVS Maintained by Canaccord Genuity -- Price Target Stays at $15 - GuruFocus
Canaccord reiterates Bioventus stock rating on growth strategy - Investing.com
Canaccord reiterates Bioventus stock rating on growth strategy By Investing.com - Investing.com India
Bioventus Inc. (BVS) Q1 2026 Earnings: Strong EPS Beat Despite Stock DeclineGross Profit Margin - dars.gov.et
Bioventus highlights PNS, PRP growth as cash flow improves and debt falls - MSN
Are Investors Undervaluing Bioventus (BVS) Right Now? - Yahoo Finance
Bioventus (BVS) Edges Lower as Stock Tests Support ZoneGamma Squeeze - newsline.com
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls - sharewise.com
Bioventus (BVS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Bioventus Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Technical Reactions to BVS Trends in Macro Strategies - Stock Traders Daily
BVS SEC FilingsBioventus Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Bioventus (BVS) director and 10% owner reports RSU grant and vesting-related share exercise - Stock Titan
Bioventus (NASDAQ: BVS) director Sutter awarded 25,146 RSUs and exercises 32,282 shares - Stock Titan
Bioventus (BVS) director granted RSUs and exercises prior awards - Stock Titan
Bioventus (BVS) director exercises RSUs and holds 148,892 shares - Stock Titan
Bioventus (BVS) director receives 25,146 RSUs and converts 32,282 into shares - Stock Titan
Bioventus (BVS) director McMurry-Heath gains shares via RSU vesting and new grant - Stock Titan
[Form 4] Bioventus Inc. Insider Trading Activity - Stock Titan
Bioventus (BVS) director Hawkins granted 30,994 RSUs and exercises 39,789 into shares - Stock Titan
Bioventus (BVS) director granted 25,146 RSUs and exercises 32,282 into shares - Stock Titan
Bioventus (BVS) director Pat Beyer receives 25,146 RSUs and converts 32,282 into Class A shares - Stock Titan
Bioventus Q1 2026 slides: earnings beat drives guidance raise - Investing.com
Bioventus Shareholders Back Directors and Auditor at 2026 Meeting - TipRanks
1.07%
자본화:
|
볼륨(24시간):